Hiroko Kishikawa

1.6k total citations
29 papers, 1.1k citations indexed

About

Hiroko Kishikawa is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hiroko Kishikawa has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Hiroko Kishikawa's work include Neonatal Respiratory Health Research (11 papers), Congenital Diaphragmatic Hernia Studies (9 papers) and Respiratory Support and Mechanisms (5 papers). Hiroko Kishikawa is often cited by papers focused on Neonatal Respiratory Health Research (11 papers), Congenital Diaphragmatic Hernia Studies (9 papers) and Respiratory Support and Mechanisms (5 papers). Hiroko Kishikawa collaborates with scholars based in United States, Australia and Spain. Hiroko Kishikawa's co-authors include I‐Cheng Ho, Shi‐Chuen Miaw, David M. Wu, Guo‐fu Hu, Jenny Sun, James C. Dabrowiak, Winnie Xin, Katherine B. Sims, David S. Lawrence and Ran Song and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Immunity.

In The Last Decade

Hiroko Kishikawa

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Kishikawa United States 17 445 396 136 127 124 29 1.1k
Steve Huang United States 15 349 0.8× 325 0.8× 69 0.5× 142 1.1× 301 2.4× 21 1.2k
A. Ischenko Russia 23 503 1.1× 835 2.1× 57 0.4× 145 1.1× 150 1.2× 50 1.6k
Susan K. Anderson United States 18 445 1.0× 349 0.9× 121 0.9× 69 0.5× 149 1.2× 30 1.3k
Gabriela Schneider United States 23 729 1.6× 189 0.5× 123 0.9× 49 0.4× 197 1.6× 55 1.1k
Mariko Kawakami United States 23 431 1.0× 657 1.7× 114 0.8× 81 0.6× 416 3.4× 52 1.4k
Mingfu Wu China 18 495 1.1× 209 0.5× 134 1.0× 80 0.6× 254 2.0× 70 1.3k
Jong-Eun Park South Korea 18 830 1.9× 342 0.9× 275 2.0× 52 0.4× 185 1.5× 44 1.5k
Tomohiko Sato Japan 22 847 1.9× 259 0.7× 103 0.8× 115 0.9× 201 1.6× 59 1.9k
Kenneth S. Zuckerman United States 24 598 1.3× 343 0.9× 84 0.6× 83 0.7× 318 2.6× 67 1.5k
Rick Kamps Netherlands 16 495 1.1× 218 0.6× 95 0.7× 43 0.3× 94 0.8× 26 1.1k

Countries citing papers authored by Hiroko Kishikawa

Since Specialization
Citations

This map shows the geographic impact of Hiroko Kishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Kishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Kishikawa more than expected).

Fields of papers citing papers by Hiroko Kishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Kishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Kishikawa. The network helps show where Hiroko Kishikawa may publish in the future.

Co-authorship network of co-authors of Hiroko Kishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Kishikawa. A scholar is included among the top collaborators of Hiroko Kishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Kishikawa. Hiroko Kishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsikis, Savas T., Scott C. Fligor, Amy Pan, et al.. (2025). Systemic heparin administration impairs lung development in neonatal mice. Scientific Reports. 15(1). 15273–15273. 1 indexed citations
2.
Tsikis, Savas T., Scott C. Fligor, Amy Pan, et al.. (2022). Direct thrombin inhibitors as alternatives to heparin to preserve lung growth and function in a murine model of compensatory lung growth. Scientific Reports. 12(1). 21117–21117. 8 indexed citations
3.
Tsikis, Savas T., Scott C. Fligor, Amy Pan, et al.. (2022). Lipopolysaccharide-induced murine lung injury results in long-term pulmonary changes and downregulation of angiogenic pathways. Scientific Reports. 12(1). 10245–10245. 44 indexed citations
4.
Yang, Hailing, Liang Yuan, Soichiro Ibaragi, et al.. (2022). Angiogenin and plexin-B2 axis promotes glioblastoma progression by enhancing invasion, vascular association, proliferation and survival. British Journal of Cancer. 127(3). 422–435. 16 indexed citations
5.
Yu, Lumeng J., et al.. (2021). Deficiency in pigment epithelium‐derived factor accelerates pulmonary growth and development in a compensatory lung growth model. The FASEB Journal. 35(10). e21850–e21850. 2 indexed citations
6.
Yu, Lumeng J., Duy T. Dao, Amy Pan, et al.. (2021). Investigation of the mechanisms of VEGF-mediated compensatory lung growth: the role of the VEGF heparin-binding domain. Scientific Reports. 11(1). 11827–11827. 8 indexed citations
7.
Dao, Duy T., Prathima Nandivada, Jacqueline Vuong, et al.. (2018). Vascular endothelial growth factor accelerates compensatory lung growth by increasing the alveolar units. Pediatric Research. 83(6). 1182–1189. 21 indexed citations
8.
Dao, Duy T., Lorenzo Anez‐Bustillos, Amy Pan, et al.. (2018). Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy. Angiogenesis. 21(4). 837–848. 12 indexed citations
9.
Li, Shuping, Jinghao Sheng, Jamie K. Hu, et al.. (2012). Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis. 16(2). 387–404. 47 indexed citations
10.
Li, Shuping, Wenhao Yu, Hiroko Kishikawa, & Guo‐fu Hu. (2010). Angiogenin prevents serum withdrawal‐induced apoptosis of P19 embryonal carcinoma cells. FEBS Journal. 277(17). 3575–3587. 20 indexed citations
11.
Ibaragi, Soichiro, Norie Yoshioka, Hiroko Kishikawa, et al.. (2009). Angiogenin-Stimulated rRNA Transcription Is Essential for Initiation and Survival of AKT-Induced Prostate Intraepithelial Neoplasia. Molecular Cancer Research. 7(3). 415–424. 35 indexed citations
12.
Kishikawa, Hiroko, et al.. (2008). Targeting angiogenin in therapy of amyotropic lateral sclerosis. Expert Opinion on Therapeutic Targets. 12(10). 1229–1242. 36 indexed citations
13.
Kishikawa, Hiroko, Ketai Wang, S. James Adelstein, & Amin I. Kassis. (2006). Inhibitory and Stimulatory Bystander Effects are Differentially Induced by Iodine-125 and Iodine-123. Radiation Research. 165(6). 688–694. 39 indexed citations
14.
Nurieva, Roza, Julie Duong, Hiroko Kishikawa, et al.. (2003). Transcriptional Regulation of Th2 Differentiation by Inducible Costimulator. Immunity. 18(6). 801–811. 125 indexed citations
15.
Kishikawa, Hiroko, et al.. (2001). The Cell Type-Specific Expression of the Murine IL-13 Gene Is Regulated by GATA-3. The Journal of Immunology. 167(8). 4414–4420. 120 indexed citations
16.
Miaw, Shi‐Chuen, et al.. (2000). ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes. Immunity. 12(3). 323–333. 121 indexed citations
17.
Kishikawa, Hiroko, Ran Song, & David S. Lawrence. (1997). Interleukin-12 Promotes Enhanced Resistance toInfection of Lead-Exposed Mice. Toxicology and Applied Pharmacology. 147(2). 180–189. 55 indexed citations
18.
Kishikawa, Hiroko, et al.. (1994). Quantitative footprinting analysis. Journal of Molecular Recognition. 7(2). 133–139. 5 indexed citations
19.
Kishikawa, Hiroko, et al.. (1991). Histidine decarboxylase measurement in brain by 14CO2 trapping. Biochemical Pharmacology. 42(2). 217–222. 8 indexed citations
20.
Kishikawa, Hiroko, Ying Jiang, Jerry Goodisman, & James C. Dabrowiak. (1991). Coupled kinetic analysis of cleavage of DNA by esperamicin and calicheamicin. Journal of the American Chemical Society. 113(14). 5434–5440. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve Huang Breakdown of academic impact, for papers by A. Ischenko Breakdown of academic impact, for papers by Susan K. Anderson Breakdown of academic impact, for papers by Gabriela Schneider Breakdown of academic impact, for papers by Mariko Kawakami Breakdown of academic impact, for papers by Mingfu Wu Breakdown of academic impact, for papers by Jong-Eun Park Breakdown of academic impact, for papers by Tomohiko Sato Breakdown of academic impact, for papers by Kenneth S. Zuckerman Breakdown of academic impact, for papers by Rick Kamps
Rankless by CCL
2026